PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Granger, Christopher
TI  - Apixaban Superior to Warfarin for Prevention of SSE in Patients with AF: Results from ARISTOTLE
DP  - 2011 Nov 01
TA  - MD Conference Express
PG  - 11--12
VI  - 11
IP  - 10
4099  - http://mdc.sagepub.com/content/11/10/11.short
4100  - http://mdc.sagepub.com/content/11/10/11.full
AB  - In patients with atrial fibrillation, apixaban is superior to warfarin in preventing stroke or systemic embolism, causes less bleeding, and results in lower mortality according to primary results from the Apixaban for Reduction In STrOke and other ThromboemboLic Events in atrial fibrillation [ARISTOTLE; NCT00412984] trial.